A previous study demonstrated that the inhibition of the FMS-like receptor tyrosine kinase-3 (FLT3) up-regulated HDAC8, which promoted p53 acetylation in AML cells with FLT3 internal tandem duplication (ITD) mutations [156]. This evidence concerns the gene HDAC8 and acute myeloid leukemia.